Cargando...
Targeting KIT in Melanoma: A Paradigm of Molecular Medicine and Targeted Therapeutics
Despite multiple clinical trials utilizing a spectrum of therapeutic modalities, melanoma remains a disease with dismal outcomes in patients with advanced disease. However, it is now clear that melanoma is not a single entity, but can be molecularly divided into subtypes that generally correspond to...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3935736/ https://ncbi.nlm.nih.gov/pubmed/20457136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2010.04.032 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|